Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias
about
The absence of reactive oxygen species production protects mice against bleomycin-induced pulmonary fibrosisMatrix Metalloproteinases in Non-Neoplastic Disorders.Always cleave up your mess: targeting collagen degradation to treat tissue fibrosisMatrix metalloproteinase-9 activates TGF-β and stimulates fibroblast contraction of collagen gelsMatrix metalloproteinases vary with airway microbiota composition and lung function in non-cystic fibrosis bronchiectasisIPF: new insight on pathogenesis and treatmentMatrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosisAlterations of serum biomarkers associated with lung ventilation function impairment in coal workers: a cross-sectional studyMMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosisIL-1 and IL-23 mediate early IL-17A production in pulmonary inflammation leading to late fibrosisBleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient miceNoninvasive monitoring of pulmonary fibrosis by targeting matrix metalloproteinases (MMPs).Cellular uptake of proMMP-2:TIMP-2 complexes by the endocytic receptor megalin/LRP-2.Emphysema is associated with increased inflammation in lungs of atherosclerosis-prone mice by cigarette smoke: implications in comorbidities of COPD.Detection of herpes simplex virus type-1 in patients with fibrotic lung diseasesMatrix metalloproteinases and protein tyrosine kinases: potential novel targets in acute lung injury and ARDSModulation of lung inflammation by the Epstein-Barr virus protein Zta.Tuberculosis, lung infections, and interstitial lung disease in AJRCCM 2000.Serum biomarker analysis of collagen disease patients with acute-onset diffuse interstitial lung disease.Gene expression changes associated with the airway wall response to injury.Chronic obstructive pulmonary disease - part 2: pathology and biochemistry of emphysema.Matrix metalloproteinase-9 in lung remodeling.Unexpected smoking-linked high MMP-9 in induced sputum of hazardous dust-exposed workers.Discoidin domain receptor 1 contributes to the survival of lung fibroblast in idiopathic pulmonary fibrosisMatrix metalloproteinase 3 is a mediator of pulmonary fibrosis.Three-dimensional analysis of alveolar wall destruction in the early stage of pulmonary emphysema.Raised plasma concentrations of alpha-defensins in patients with idiopathic pulmonary fibrosis.Matrix metalloproteinases promote inflammation and fibrosis in asbestos-induced lung injury in miceOxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy.Acute exacerbations of idiopathic pulmonary fibrosisMatrix metalloproteinases in destructive pulmonary pathology.Profibrotic activities for matrix metalloproteinase-8 during bleomycin-mediated lung injuryInterfering with extracellular matrix degradation to blunt inflammationAcute exacerbations in patients with idiopathic pulmonary fibrosis.SIRT1 redresses the imbalance of tissue inhibitor of matrix metalloproteinase-1 and matrix metalloproteinase-9 in the development of mouse emphysema and human COPD.Matrix metalloproteases in bronchoalveolar lavage fluid of patients with type III Pseudomonas aeruginosa pneumonia.Pathogenesis of pulmonary fibrosis in systemic sclerosis: lessons from interstitial lung disease.Activation of Tissue Remodeling Precedes Obliterative Bronchiolitis in Lung Transplant RecipientsTissue is an issue in the search for biomarkers in idiopathic pulmonary fibrosis.Facts and promises on lung biomarkers in interstitial lung diseases.
P2860
Q24803487-8A716D1E-1A94-4DF8-8BEC-FADE4CB6398BQ26741827-06AB70DE-43A6-4533-A691-BB4A8A230658Q26827393-2D46BA14-D561-46C0-8A74-C42669223480Q28237556-0BAF9730-1F4D-41E2-A096-12BC414E44C5Q28256930-298B9694-5954-4848-BC2A-A3874EF10B53Q28272013-6CD32C50-4694-41F2-9FA4-10B159F1079BQ28386047-0A796916-5D5F-4C8D-BCD3-380AC496F509Q28392653-25D2855A-A3FA-4EFC-A756-FD46CE3814DFQ28472658-338F896D-7381-46B9-85F2-A1B5A14E0826Q28476584-692F2894-9FA7-4AAA-88E6-7BDEFE9A88A4Q28594381-F07AAE05-01F3-4A50-AC9E-A8CE004583D6Q30540289-BA65629F-EF98-4513-8E58-C190AD93B2A6Q33849227-88758519-52D5-4632-A21A-534FD0EA9C50Q34053824-10D2C33E-1502-40D3-8127-0F92696C370BQ34113496-C8A3941E-92F2-4CA3-933E-C2CA56417874Q34299797-5946B50A-591E-4554-8CF0-D324DF332057Q34426098-D6019548-92C7-4A28-AD8B-A8F09418521CQ34457540-6DC611E2-1FD6-4DEC-8BE7-48849EDAA80FQ34584869-EFE31517-7EFB-4C86-B7BE-E503DAD2860FQ34672278-6F030E37-F411-445C-8C2A-04F952CD843CQ34802380-80C669F2-A483-41A3-B825-58A2DD098461Q35032152-F108EC96-19EA-4A04-ADAB-923FECEBCAE7Q35070573-097FC13B-830B-47F7-957D-83F65FA80BC8Q35088066-2E2E8639-1C5C-411A-934B-CA74DB5CEEBEQ35235706-A735C4D4-C429-4019-8042-7DAB9EADB9D3Q35252279-66C65FF5-B960-433E-818C-2CCC892DC5B3Q35535282-C7415DE3-D646-45FA-BC82-94E756B214A1Q35676548-23F905AF-327B-4A01-A9EF-56B952205811Q36128020-58CE5D6C-06B5-4BC7-9A06-C2FAB3470808Q36168860-F57772AE-644B-4E23-A1EA-D7B5B852594AQ36287585-F326ECD4-BE7E-489B-893C-16676395AE63Q36803400-4EF28BCB-11B6-4BC4-B137-16EA36930E42Q37112292-F81D1FCD-DB18-4F60-8AE3-F62D7008E764Q37152742-D16BC9A4-EF7C-4B8D-B8E4-BC3461F6B40CQ37342209-589D3475-4632-4228-926C-3433EF134247Q37373550-9D01F969-CBB5-4CD1-925F-B6303B3CE059Q37738691-864191F8-C305-432F-80E1-E6DF67300B44Q38294941-C0D38345-1EE9-448A-BA2F-301F184C6EF8Q38367113-35029BF9-A38C-4403-AA1A-B203A134DFACQ38543042-7743B8E9-D472-4E6F-93BE-E81E5F3D513A
P2860
Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Characteristic elevation of ma ...... pathic interstitial pneumonias
@ast
Characteristic elevation of ma ...... pathic interstitial pneumonias
@en
Characteristic elevation of ma ...... pathic interstitial pneumonias
@nl
type
label
Characteristic elevation of ma ...... pathic interstitial pneumonias
@ast
Characteristic elevation of ma ...... pathic interstitial pneumonias
@en
Characteristic elevation of ma ...... pathic interstitial pneumonias
@nl
prefLabel
Characteristic elevation of ma ...... pathic interstitial pneumonias
@ast
Characteristic elevation of ma ...... pathic interstitial pneumonias
@en
Characteristic elevation of ma ...... pathic interstitial pneumonias
@nl
P2093
P2860
P3181
P1476
Characteristic elevation of ma ...... pathic interstitial pneumonias
@en
P2093
H Miyakawa
P2860
P304
P3181
P356
10.1164/AJRCCM.162.5.9906096
P407
P577
2000-11-01T00:00:00Z